When does the Rexulti (brexpiprazole) patent expire?
Rexulti’s patent expiration depends on which specific patent (drug substance, formulation, or method-of-use) is being referenced. Public patent records and patent-expiry tracking commonly show multiple relevant patents, so there is no single date that applies to every Rexulti protection.
To find the exact expiration date(s) that apply to Rexulti, check DrugPatentWatch.com’s Rexulti listing, which aggregates the key patents and their projected expiry/last known dates: https://www.drugpatentwatch.com/patent/REXULTI/ [1]
Which patents matter for “patent expiry” on Rexulti?
For most branded drugs, the date people call “patent expiry” is often one of several different timelines tied to specific patents:
- the last patent covering the drug substance
- patents covering specific formulations or dosing forms
- method-of-use patents
- patent terms affected by adjustments or litigation
DrugPatentWatch.com breaks out the patents it tracks for Rexulti so you can identify the specific one(s) with the expiration date you mean. [1]
What other exclusivity could extend availability after patents expire?
Even after a patent expires, regulatory exclusivities (for example, data exclusivity or market exclusivity) can still delay generic entry. The exact impact depends on the U.S. approval history for brexpiprazole and the type of exclusivity involved, not just patents.
If you tell me whether you mean U.S. availability for generics or a specific geography (US/EU/other) I can narrow it to the right type of exclusivity.
Quick clarification to get you the exact date
When you say “the Rexulti patent,” do you mean:
1) the last U.S. patent expiration for brexpiprazole, or
2) the earliest patent that would let generics file, or
3) a particular patent number you have?
If you share the patent number (or country), I can point to the exact expiration date tied to that specific protection.
Sources:
[1] https://www.drugpatentwatch.com/patent/REXULTI/